Hillevax

Hillevax R&D Expenses

Delisted

The Research & Development Expenses of Hillevax (HLVX) as of Nov 20, 2026 is 78.17 M USD. In the previous year, Research & Development Expenses was 106.68 M USD — a change of -26.72% (lower).

R&D Expenses

78.17 MUSD

YoY

-26.72%

Last updated:

Research & Development Expenses of Hillevax is 2024 78.17 M USD. Research & Development Expenses of Hillevax was 2023 106.68 M USD. It decreases by -26.72% lower compared to the previous year.

The Hillevax R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2020
0.00 USD
Jan 1, 2021
10.01 M USD
Jan 1, 2022
45.91 M USD
Jan 1, 2023
106.68 M USD
Jan 1, 2024
78.17 M USD
The Hillevax R&D Expenses history
YEARR&D ExpensesYoY
78.17 MUSD-26.72%
106.68 MUSD+132.38%
45.91 MUSD+358.44%
10.01 MUSD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax Stock analysis

What does Hillevax do? HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs. Hillevax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hillevax stock

Research & Development Expenses of Hillevax is 78.17 M USD in 2024.

Research & Development Expenses of Hillevax changed from 106.68 M USD to 78.17 M USD, representing a -26.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Hillevax since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Hillevax historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hillevax

All Key Metrics — Hillevax